Differential regulation of cell survival by CD40

被引：50

作者：

Dallman, C ^{[1
]}

Johnson, PWM ^{[1
]}

Packham, G ^{[1
]}

机构：

[1] Univ Southampton, Southampton Gen Hosp, Canc Sci Div, Canc Res UK Oncol Unit, Southampton SO16 6YD, Hants, England

来源：

APOPTOSIS | 2003年 / 8卷 / 01期

关键词：

apoptosis; cancer; CD40; receptor; therapy;

D O I：

10.1023/A:1021696902187

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The CD40 cell surface receptor is required for normal function of the immune system and is a positive regulator of cell survival for normal B-lymphocytes. However, there is evidence to support both pro- and anti-apoptotic functions for CD40 in malignant B-cells and epithelial cancers. There is increasing interest in the potential of CD40 activating agents as novel therapies for cancer and it is essential to understand the differential response of malignant cells, to inform the design of trials. Here we review the current understanding of differential responses to CD40 activation and apoptosis controlling proteins regulated by CD40 that might account for these effects.

引用

页码：45 / 53

页数：9

共 95 条

[1] The Bcl-2 protein family: Arbiters of cell survival [J].

Adams, JM ;

Cory, S .

SCIENCE, 1998, 281 (5381) :1322-1326

[2] Expression and prognostic significance of survivin in de novo acute myeloid leukaemia [J].

Adida, C ;

Recher, C ;

Raffoux, E ;

Daniel, MT ;

Taksin, AL ;

Rousselot, P ;

Sigaux, F ;

Degos, L ;

Altieri, DC ;

Dombret, H .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :196-203

[3]

Adida C, 2000, BLOOD, V96, P1921

[4] CD40 activation-induced, Fas-dependent apoptosis and NF-κB/AP-1 signaling in human intrahepatic biliary epithelial cells [J].

Afford, SC ;

Ahmed-Choudhury, J ;

Randhawa, S ;

Russell, C ;

Youster, J ;

Crosby, HA ;

Eliopoulos, A ;

Hubscher, SG ;

Young, LS ;

Adams, DH .

FASEB JOURNAL, 2001, 15 (13) :2345-2354

[5] Role for CD40-CD40 ligand interactions in the immune response to solid tumours [J].

Alexandroff, AB ;

Jackson, AM ;

Paterson, T ;

Haley, JL ;

Ross, JA ;

Longo, DL ;

Murphy, WJ ;

James, K ;

Taub, DD .

MOLECULAR IMMUNOLOGY, 2000, 37 (09) :515-526

[6] THE PROTOONCOGENE BCL-2 CAN SELECTIVELY RESCUE NEUROTROPHIC FACTOR-DEPENDENT NEURONS FROM APOPTOSIS [J].

ALLSOPP, TE ;

WYATT, S ;

PATERSON, HF ;

DAVIES, AM .

CELL, 1993, 73 (02) :295-307

[7] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].

Ambrosini, G ;

Adida, C ;

Altieri, DC .

NATURE MEDICINE, 1997, 3 (08) :917-921

[8]

Andersen NS, 2000, BLOOD, V96, P2219

[9] The Bcl-2 protein family [J].

Antonsson, B ;

Martinou, JC .

EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :50-57

[10] Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand [J].

Baker, MP ;

Eliopoulos, AG ;

Young, LS ;

Armitage, RJ ;

Gregory, CD ;

Gordon, J .

BLOOD, 1998, 92 (08) :2830-2843

← 1 2 3 4 5 6 7 8 9 10 →